Disability Level and Trunk Control in Individuals With Multiple Sclerosis
NCT ID: NCT05634993
Last Updated: 2025-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2022-06-01
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trunk Restraint in Multiple Sclerosis
NCT06982833
Trunk Control and Disability in Persons With Multiple Sclerosis
NCT06327789
Body Awareness, Trunk Stability, and Arm Function in MS
NCT07151534
Respiratory Functions, Trunk Control and Mobility Evaluation in Multiple Sclerosis
NCT03826095
Impact of Core Performance on Functional Parameters in Multiple Sclerosis
NCT04750733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MS Group
Assessment
Assessment of disability level and trunk control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment
Assessment of disability level and trunk control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a definite diagnosis of MS
* Expanded Disability Status Scale (EDSS) score of 8.5 and below
* Not having an attack in the last 3 months
Exclusion Criteria
* Having severe vision and hearing problems
* The presence of severe cognitive impairment detected by the physician at a level that prevents the tests from being performed.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bandırma Onyedi Eylül University
OTHER
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melike Sumeyye Ozen
Research Assistant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Melike Sumeyye Ozen
Bandırma, Balıkesir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-42
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.